In the present study, the numbers of platelet-cancer cell aggregates increased with almost each week of breast cancer progression, and it cannot be excluded that the GPIIb/IIIa complex plays a considerable role in this process, being one of several platelet receptors involved in the formation of these aggregates with tumor cells. This evidence concerns the gene ITGA2B and neoplasm.